PharmaTher PHRRF Stock
PharmaTher Price Chart
PharmaTher PHRRF Financial and Trading Overview
| PharmaTher stock price | 0.08 USD |
| Previous Close | 0.4 USD |
| Open | 0.41 USD |
| Bid | 0.34 USD x 8000000 |
| Ask | 0.36 USD x 2500000 |
| Day's Range | 0.33 - 0.41 USD |
| 52 Week Range | 0.12 - 0.43 USD |
| Volume | 573.49K USD |
| Avg. Volume | 433.32K USD |
| Market Cap | 31.41M USD |
| Beta (5Y Monthly) | 3.542 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PHRRF Valuation Measures
| Enterprise Value | 33.64M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 25.05 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -24.336 |
Trading Information
PharmaTher Stock Price History
| Beta (5Y Monthly) | 3.542 |
| 52-Week Change | 143.82% |
| S&P500 52-Week Change | 19.28% |
| 52 Week High | 0.43 USD |
| 52 Week Low | 0.12 USD |
| 50-Day Moving Average | 0.28 USD |
| 200-Day Moving Average | 0.19 USD |
PHRRF Share Statistics
| Avg. Volume (3 month) | 433.32K USD |
| Avg. Daily Volume (10-Days) | 791.17K USD |
| Shares Outstanding | 88.52M |
| Float | 70.98M |
| Short Ratio | N/A |
| % Held by Insiders | 19.46% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | May 31, 2024 |
| Most Recent Quarter (mrq) | February 28, 2025 |
| Next Fiscal Year End | May 31, 2025 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -38.98% |
| Return on Equity (ttm) | -76.14% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -1382365 USD |
| Net Income Avi to Common (ttm) | -1477919 USD |
| Diluted EPS (ttm) | -0.04 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.29M USD |
| Total Cash Per Share (mrq) | 0.02 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 4.356 |
| Book Value Per Share (mrq) | 0.014 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1238787 USD |
| Levered Free Cash Flow (ttm) | -758513 USD |
Profile of PharmaTher
| Country | United States |
| State | ON |
| City | Toronto |
| Address | 82 Richmond Street East |
| ZIP | M5C 1P1 |
| Phone | 888-846-3171 |
| Website | https://www.pharmather.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. The company's product pipeline includes KETARX, a ketamine hydrochloride injection for the treatment of Parkinson's disease, Amyotrophic Lateral Sclerosis, complex regional pain, and anesthesia and procedural sedation. It develops KETARX, a microneedle patch, for mental health, neurological, and pain disorders; and KETARX On-body pump for the maintenance of general anesthesia for diagnostic and surgical procedures. In addition, the company offers PHARMAPATCH, a microneedle patch technology solution, which includes hydrogel-forming and gelatin methacryloyl delivery system for the treatment of psychedelics and infectious diseases. Further, it has license agreement with BioRAE, Inc. for the development and commercialization of a novel biocompatible and biodegradable gelatin methacryloyl microneedle; and the University of Kansas to develop and commercialize the intellectual property of ketamine to treat ALS; as well as holds a patent and know-how license agreement with The Queen's University of Belfast to develop and commercialize hydrogel-forming microneedle patch delivery technology. The company was incorporated in 2019 and is headquartered in Toronto, Canada.
Q&A For PharmaTher Stock
What is a current PHRRF stock price?
PharmaTher PHRRF stock price today per share is 0.08 USD.
How to purchase PharmaTher stock?
You can buy PHRRF shares on the OTC Markets OTCQB exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for PharmaTher?
The stock symbol or ticker of PharmaTher is PHRRF.
Which industry does the PharmaTher company belong to?
The PharmaTher industry is Biotechnology.
How many shares does PharmaTher have in circulation?
The max supply of PharmaTher shares is 92.06M.
What is PharmaTher Price to Earnings Ratio (PE Ratio)?
PharmaTher PE Ratio is now.
What was PharmaTher earnings per share over the trailing 12 months (TTM)?
PharmaTher EPS is -0.01 USD over the trailing 12 months.
Which sector does the PharmaTher company belong to?
The PharmaTher sector is Healthcare.